원료의약품
Quetiapine Fumarate (쿠에티아핀푸마르산염)
KDMF APIs
Quetiapine Fumarate
품목명 (한글) | 쿠에티아핀푸마르산염 |
|---|---|
분류 | 중추신경계 |
CAS No. | 111974-72-2 |
KDMF 등록번호 | 20120713-172-I-90-05 |
제조원 | Mylan Laboratories Limited Qilu Tianhe Pharmaceutical Co., Ltd. |
규격 | USP |
품목 정보
IUPAC Name | 2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaen-10-yl}piperazin-1-yl)ethoxy]ethan-1-ol |
|---|---|
Synonyms | 2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol |
Description | Initially approved by the FDA in 1997, quetiapine is a second-generation atypical antipsychotic used in schizophrenia, major depression, and bipolar disorder. Quetiapine demonstrates a high level of therapeutic efficacy and low risk of adverse effects during long-term treatment. It is well-tolerated and a suitable option for some patients with high sensitivity to other drugs, such as Clozapine and Olanzapine. |
Certificate of Analysis | If you need more information, please contact us. |
규격서·시험성적서 등 추가 자료가 필요하시면 문의 시 함께 요청해 주세요. 담당자가 확인 후 회신드립니다. (02-579-1056 · ace@acebiopharm.com)